UnitedHealth announced its plan to buy Amedisys, a major home health care provider, more than a year ago. Home health is a ...

The U.S. Department of Justice (DOJ) and four state attorneys general filed a lawsuit to block UnitedHealth Group’s (NYSE: ...

UnitedHealth Group’s $3.3 billion acquisition of Amedisys faces a new hurdle as the U.S. Department of Justice sued to block ...

NEW YORK -- The Justice Department is suing to block UnitedHealth Group's $3.3 billion purchase of Amedisys, citing concerns ...

Amedisys (NASDAQ:AMED) quickly dropped 4.2% after a report that the Dept. of Justice is leaning toward filing a lawsuit to challenge UnitedHealthcare's (UNH) planned acquisition. The regulator ...

Amedisys shares have risen roughly 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $97.71, a rise of nearly 6% in the last 12 months.

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of Amedisys, Inc. (Symbol: AMED) entered into oversold territory, hitting an RSI reading of ...

Get prepared with the key expectations. Quest Diagnostics, Encompass Health, Amedisys and Addus HomeCare have been highlighted in this Industry Outlook article. Dependence on telehealth and AI ...

Elon Musk to lead a new government department, Exxon CEO cautions against leaving Paris climate agreement, more news to start ...

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported third-quarter earnings of $16.9 million. The Baton Rouge, Louisiana-based company said it had net ...